Birdwatch Archive

Birdwatch Note

2023-03-10 02:56:20 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Ivermectin and Hydroxychloroquine have been shown not to have efficacy in COVID-19 based on randomized controlled trials https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://www.sciencedirect.com/science/article/pii/S1477893921001769 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013587.pub2/full

Written by 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1633372186567163904

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1634025363381649408
  • noteId - 1634025363381649408
  • participantId - 7554BE30DC1ACBA237371B5EFA9AFEE56A40F40178D64EB403F2D35E5AB5AD31
  • noteAuthorParticipantId -
  • createdAtMillis - 1678416980009
  • tweetId - 1633372186567163904
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Ivermectin and Hydroxychloroquine have been shown not to have efficacy in COVID-19 based on randomized controlled trials https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full https://www.sciencedirect.com/science/article/pii/S1477893921001769 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013587.pub2/full

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-03-10 02:56:20 UTC
(1678416980009)		 1969-12-31 23:59:59 UTC
(-1)		 2023-03-11 02:40:40 UTC
(1678502440177)		 NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-03-10 23:52:30 -0600 04E2677FECB361D0C3F2917DE54010C0150E653D5BCBAA8214B937B8F8611EAB Rating Details
2023-03-10 23:54:03 -0600 0E3D268AE0A5CFBA11DCBB42E6EB1DA36B118A1775BD01D9E9188742DD168F33 Rating Details
2023-03-10 23:17:21 -0600 1D228D8799BCD729C3C2DAC0D22767201D87660CB53831CD6ABDE890163FD7B0 Rating Details
2023-03-10 23:04:35 -0600 1E63C4F17963B9C5B4489BFDF29FE99946F4AFDBE9F44C5F9A9F6119EB7A78A4 Rating Details
2023-03-10 03:11:20 -0600 25BB127132A919E13A0F95968D39AB41C3C258706013CE9131271FB395AE7859 Rating Details
2023-03-10 22:30:57 -0600 2EBF26F60F3A7E9005DA089FC61E341428510E1CA440226B1C2CB0CD463748D6 Rating Details
2023-03-10 23:35:00 -0600 373B7DE50DC490C95349BF11A8506D7AE8CF893E3549D14DAF3F504E1DE61796 Rating Details
2023-03-10 02:16:32 -0600 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 Rating Details
2023-03-09 21:09:50 -0600 45B8EF43682258D990F1C39DD9C1C131E030B7B116A1A874CAD37AED55F98C04 Rating Details
2023-03-10 21:47:21 -0600 46F0DC2E2D70C72230C79A6A095CB48DF62F70780D4D060F0066947AE4F2BD77 Rating Details
2023-03-09 22:02:46 -0600 5EDC2B8BBEA2C25FBA40E8849AF6DD751A4AE52F674E4E2311C09F82909AD4F8 Rating Details
2023-03-11 00:36:33 -0600 6361E24B10267366034475DFF80A430CD0A757429D12CFAD95CD144862D9925F Rating Details
2023-03-10 23:29:28 -0600 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C Rating Details
2023-03-10 23:58:23 -0600 83F8C9FBF04EDF7CE0402610D70596E31ACF4323833A5EAB7FFC83BF5104A1FC Rating Details
2023-03-09 23:18:27 -0600 94D6F49DC83AD218D6D405C9224306ADA3B6AE0FF56571D96CB7C9E4156C9208 Rating Details
2023-03-10 22:47:44 -0600 9AD595B701167DE73F25FC67E8E758737FE297EB40C6B14DFA15EAE009148C91 Rating Details
2023-03-10 22:17:41 -0600 9B5E7654114B589A3A4E99761C67F6947C8929874AA1F71C4EBE23FA3F1CCB69 Rating Details
2023-03-10 23:37:05 -0600 A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 Rating Details
2023-03-10 08:54:26 -0600 A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 Rating Details
2023-03-11 00:15:20 -0600 B05E5A9FEAD2BBD12C27CCE2AF5EC06458B98D232AA85096BCC6FF412C1BEF6A Rating Details
2023-03-10 23:57:25 -0600 B398971BD5E0833FC4A6A2C3EDF5D99B4E15159FCE39719A510FEDDBE224E9C9 Rating Details
2023-03-09 21:27:32 -0600 C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 Rating Details
2023-03-10 22:36:17 -0600 C4AB10E196962EA212F4C3584870BD8DB89E319FC530438A8AA8E5A0F039EEC9 Rating Details
2023-03-09 21:31:11 -0600 C90C535484C4D52ED31381955CA67F06C8A969E1220D779EE2B05BE1BBDD4DEF Rating Details
2023-03-10 10:09:53 -0600 C966E0BA5803EDA2B9ADEA1A226B5D5FB13629349A2D9A920F01C5137F8AF13B Rating Details
2023-03-10 22:34:03 -0600 C98CEE3F2E66E72726CD7AD409074665313A54ABB141644DE5419482795A7FEA Rating Details
2023-03-11 00:20:42 -0600 C9C34F952E2BB4CB57435A01514DF0F382E499358CE3F83955CC9C266B466937 Rating Details
2023-03-11 00:10:07 -0600 D45A2C2D0A01452EB4CAC563989CA4D4828760FB2A92310BCB8E87CE1A83E5A9 Rating Details
2023-03-10 23:04:26 -0600 DED02447B6E5427B0E780F7ED69CBB4CBCEA6575BDF3F728311897471FC29442 Rating Details
2023-03-10 23:05:41 -0600 EC97263BF880B8C927BE5FA63BFE4DC5AFD8B887C34105CF1B7E580C82EECDED Rating Details
2023-03-10 22:15:24 -0600 FE2879C337844B80A8A3017D0A3989836395C07BFB78700345FD47046E8C47BA Rating Details
2023-03-10 23:00:32 -0600 FF6E19F158BFF55BD3EB79A4E772F94D88276C0B4FDA42A51CAA364E0ED5D54A Rating Details
2023-03-14 02:28:40 -0500 Rating Details
2023-03-13 21:15:44 -0500 Rating Details
2023-03-21 18:18:40 -0500 Rating Details
2023-03-21 16:32:27 -0500 Rating Details
2023-03-21 21:55:43 -0500 Rating Details
2023-03-21 20:33:43 -0500 Rating Details
2023-04-07 20:24:27 -0500 Rating Details
2023-03-10 23:54:03 -0600 Rating Details
2023-03-10 23:17:21 -0600 Rating Details
2023-03-10 10:09:53 -0600 Rating Details
2023-03-10 22:17:41 -0600 Rating Details
2023-03-10 23:04:35 -0600 Rating Details
2023-03-09 21:09:50 -0600 Rating Details
2023-03-21 16:32:27 -0500 Rating Details
2023-04-07 20:24:27 -0500 Rating Details
2023-03-11 00:10:07 -0600 Rating Details
2023-03-10 08:54:26 -0600 Rating Details
2023-03-14 02:28:40 -0500 Rating Details
2023-03-09 21:27:32 -0600 Rating Details
2023-03-10 02:16:32 -0600 Rating Details
2023-03-21 20:33:43 -0500 Rating Details
2023-03-10 22:36:17 -0600 Rating Details
2023-03-10 22:15:24 -0600 Rating Details
2023-03-10 03:11:20 -0600 Rating Details
2023-03-10 23:04:26 -0600 Rating Details
2023-03-11 00:36:33 -0600 Rating Details
2023-03-11 00:20:42 -0600 Rating Details
2023-03-21 18:18:40 -0500 Rating Details
2023-03-10 23:58:23 -0600 Rating Details
2023-03-10 22:30:57 -0600 Rating Details
2023-03-10 23:05:41 -0600 Rating Details
2023-03-21 21:55:43 -0500 Rating Details
2023-03-10 23:37:05 -0600 Rating Details
2023-03-10 23:29:28 -0600 Rating Details
2023-03-10 23:57:25 -0600 Rating Details
2023-03-10 23:00:32 -0600 Rating Details
2023-03-10 22:34:03 -0600 Rating Details
2023-03-11 00:15:20 -0600 Rating Details
2023-03-10 22:47:44 -0600 Rating Details
2023-03-13 21:15:44 -0500 Rating Details
2023-03-10 21:47:21 -0600 Rating Details
2023-03-09 22:02:46 -0600 Rating Details
2023-03-09 23:18:27 -0600 Rating Details
2023-03-10 23:35:00 -0600 Rating Details
2023-03-10 23:52:30 -0600 Rating Details